Click here for more information about laboratory operations and procedures
Lymphogranuloma venereum Antibody Panel (New test)
| Item | Value | ||||||
|---|---|---|---|---|---|---|---|
| Available Stat? | No | ||||||
| Test code | LGV | ||||||
| Performed by | Quest | ||||||
| Sendout? | Yes | ||||||
| Method | Micro-indirect fluorescence | ||||||
| Container type | Red top or Gold top | ||||||
| Amount to Collect | 2 mL blood | ||||||
| Sample type | Serum | ||||||
| Preferred volume | 1 mL serum | ||||||
| Min. Volume | 0.2 mL serum | ||||||
| Processing notes | Spin and freeze aliquot at -20C. Ship to CB. | ||||||
| Units | Titer | ||||||
| Normal range |
|
||||||
| Synonyms | LGV | ||||||
| Stability | Room temperature 1 week, refrigerated 2 weeks, frozen 1 month | ||||||
| Turn around times | 5-7 days | ||||||
| Additional information | Lymphogranuloma venereum (LGV) is a clinical syndrome caused by infection with serovars L1, L2, or L3 of C. trachomatis. Due to the highly crossreactive nature of the C. trachomatis (L2) antigen used in this panel, antibodies induced by infection with C. trachomatis (D-K) or other chlamydial species often show strong L2 reactivity. Thus, detection of L2-reactive antibodies does not necessarily indicate infection with LGV serovars of C. trachomatis. Results for the whole Chlamydia antibody panel should be considered in conjunction with clinical findings to establish the diagnosis. Includes: C. pneumoniae IgA, C. psittaci IgA, C. trachomatis (L2) IgA, C. trachomatis (D-K) IgA, C. pneumoniae IgG,C. trachomatis (L2) IgG, C. psittaci IgG, C. trachomatis (D-K) IgG, C. trachomatis (D-K) IgM, C. pneumoniae IgM, C. psittaci IgM, C. trachomatis (L2) IgM |
||||||
| CPT coding | 86632-90 x4, 86631-90 x8 | ||||||
| Last Updated | 9/9/2012 1:26:04 PM | ||||||
| Entry Number | 1468 |
If you have additional questions regarding this test, please call: 415-353-1667